Login / Signup

Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol.

Ynke LarivièreTrésor ZolaElke StoppieVivi MaketaJunior MatangilaPatrick MitashiJessie De BieHypolite Muhindo-MavokoJean-Pierre Van GeertruydenPierre Van Damme
Published in: BMJ open (2021)
NCT04186000; Pre-results.
Keyphrases
  • open label
  • clinical trial
  • study protocol
  • healthcare
  • phase ii
  • phase iii
  • randomized controlled trial
  • phase ii study
  • double blind
  • squamous cell carcinoma
  • health information
  • affordable care act